Kahane I, Granek J, Reisch-Saada A 1984. The adhesins of Mycoplasma gallisepticum and M. Pneumoniae Ann.Microbiol. 135 A:25-32
Saada AB, Kahane I. 1988. Purification and characterization of urease from Ureaplasma urealyticum. Zentralbl Bakteriol Mikrobiol Hyg [A].;269:160-167
Saada AB, Deutch V, Kahane I. 1998.Interaction of a monoclonal antibody with the urease of Ureaplasma urealyticum. FEMS lett. 1988 55: 187-190
Kahane I. Reisch-Saada A. Almagor M. Abeliuch P. Yatziv S. 1990.Glycosidase activites of mycoplasmas Zentralbl Bakteriol Mikrobiol Hyg. 273:300-305
Saada AB, Terespolski Y, Adoni A, Kahane I. 1991.Adherence of Ureaplasma urealyticum to human erythrocytes. Infect Immun.;59: 467-9
Aamar S, Saada A, Rotshenker S. 1992. Lesion-induced changes in the production of newly synthesized and secreted apo-E and other molecules are independent of the concomitant recruitment of blood-borne macrophages into Injured peripheral nerves. J Neurochem. 59:1287-92
Reichert F, Saada A, Rotshenker S. 1994 Peripheral nerve injury induces Schwann cells to express two macrophage phenotypes: phagocytosis and the galactose-specific lectin MAC-2. J Neurosci. 14:3231-45
Saada A, Dunaevsky-Hutt A, Aamar A, Reichert F, Rotshenker S. 1995. Fibroblasts that reside in mouse and frog injured peripheral nerves produce apolipoproteins. J Neurochem. 64:1996-2003
Saada A, Reichert F, Rotshenker S. 1996.Granulocyte macrophage colony stimulating factor produced in lesioned peripheral nerves induces the up-regulation of cell surface expression of MAC-2 by macrophages and Schwann cells. J Cell Biol. 133:159-67
Berger I, Elpeleg ON, Saada A.1996 Lipoamide dehydrogenase activity in lymphocytes. Clin Chim Acta 256:197-201
Elpeleg ON, Saada AB, Shaag A, Glustein JZ, RuitenbeekW, Tein I, Halevy J. 1996. Lipoamide dehydrogenase deficiency: a new cause for recurrent myoglobinuria Muscle Nerve. 20:238-40
Elpeleg ON, Shaag A, Glustein JZ, Anikster Y, Joseph A, Saada A. 1997. Lipoamide dehydrogenase deficiency in Ashkenazi Jews: an insertion mutation in the mitochondrial leader sequence. Hum Mutat. 10:256-257
Aptowitzer I, Saada A, Faber J, Kleid D, Elpeleg ON.1997. Liver disease in the Ashkenazi-Jewish lipoamide dehydrogenase deficiency. J Pediatr Gastroenterol Nutr. 24:599-601
Shaag A, Saada A, Steinberg A, Navon P, Elpeleg ON.1997. Mitochondrial encephalomyopathy associated with a novel mutation in the mitochondrial tRNA(leu)(UUR) gene (A3243T). Biochem Biophys Res Commun. 233:637-639
Be'eri H, Reichert F, Saada A, Rotshenker S. 1998The cytokine network of Wallerian degeneration: IL-10 and GM-CSF. Eur J Neurosci. 10:2707-2713
Link G, Saada A, Pinson A, Konijn AM, Hershko C. 1998.Mitochondrial respiratory enzymes are a major target of iron toxicity in rat heart cells. J Lab Clin Med. 131:466-474
Cohen O, Steiner I, Argov Z, Ashkenazi A, Diment J, Saada A, River Y. 1998. Mitochondrial myopathy with atypical subacute presentation. J Neurol Neurosurg Psychiatry. 64:410-411
Shaag A, Saada A, Berger I, Mandel H, Joseph A, Feigenbaum A, Elpeleg ON. 1999. Molecular basis of lipoamide dehydrogenase deficiency in Ashkenazi Jews. Am J Med Genet. 82:177-182
Shany E, Saada A, Landau D, Shaag A, Hershkovitz E, Elpeleg ON.1999. Lipoamide dehydrogenase deficiency due to a novel mutation in the interface domain. Biochem Biophys Res Commun. 262:163-166
Saada A, Aptowitzer I, Link G, Elpeleg ON. 2000. ATP synthesis in lipoamide dehydrogenase deficiency. Biochem Biophys Res Commun 269:382-386
Elpeleg ON, Hammerman C, Saada A, Shaag A, Golzand E, Hochner-Celnikier D, Berger I, Nadjari M. 2001. The antenatal presentation of carnitine palmitoyl transferase II deficiency. Am J Med Genet. 102:183-187
Mandel H, Szargel R, Labay V, Elpeleg O, Saada A, Shalata A, Anbinder Y, Berkowitz D, Hartman C, Barak M, Eriksson S, Cohen N. 2001.The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat genet. 337-41
Saada A , Mandel H, Nevo Y, Eriksson S, Elpeleg O.2001. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet. 29:342-343.
Bar-Meir, Elpeleg O, Saada A.2001. Effect of various agents on adenosine triphosphate synthesis in mitochondrial complex I deficiency. J Pediatr. 139:868-870
Elpeleg O, Mandel H, Saada A.2002. Depletion of the other genome Mitochondrial depletion syndrome in humans. J.Molec. Med. 80:389-396
Nevo Y, Soffer D, Kutai M, Zelnik N, Saada A, Jossiphov J, Messer G, Shaag A, Shahar E, Harel S, Elpeleg O. 2002. Clinical characteristics and muscle pathology in myopathic mitochondrial DNA depletion. Child Neurol. 17: 499- 504
Lev D, Gilad E, Leshinsky-Silver E, Houri S, Levine A, Saada A, Lerman-Sagie T. 2002.Reversible fulminant lactic and liver failure in an Infant with Hepatic Cytochrome C Oxidase Deficiency. J Inherit Metab Dis. 25:371-377
Saada A, Shaag A, Elpeleg O. 2003.MtDNA depletion myopathy: elucidation of the Tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency Molec Gen Metab.2003;79:1-5
Wang L, Saada A, Eriksson S. 2003. Kinetic properties of mutant thymidine kinase 2 suggest a mechanism for mitochondrial DNA depletion myopathy. J. Biol. Chem. 278:6963-6968
Saada A, Ben-Shalom E, Zyslin R, Miller C, Mandel H, Elpeleg O.2003. Mitochondrial Deoxyribonucleoside triphosphate pools in thymidine kinase 2 deficiency. Biochem. Biophys. Res. Commun.; 310:963-966
Miller C, Saada A, Shaul N, Shabtai N, Ben-Shalom E, Shaag A, Herskowitz E, Elpeleg O.2004 Defective mitochondrial translation due to a ribosomal protein (MRPS16) mutation. Ann Neurol 56:734-738
Saada A. Bar-Meir M, Belaiche C, Miller C, Elpeleg O. 2004 Evaluation of enzymatic assays and compounds affecting ATP production in mitochondrial respiratory chain complex I deficiency. Anal.Biochem 335:66-72
Saada-Reisch A. 2004 Deoxyribonucleoside kinases in mitochondrial DNA depletion. Nucleotides,Nucleotides and Nucleic Acids: 23:127-137
Lamont PJ, Thorburn DR, Fabian V, Vajsar J, Hawkins C, Saada Reisch A, Durling H, Laing NG, Nevo Y.2004. Nemaline rods and complex I deficiency in three infants with hypotonia, motor delay and failure to thrive. Neuropediatrics. 2004;35:302-306
Saada A. 2004 Deoxyribonucleotides and disorders of mitochondrial DNA integrity. DNA & Cell Biol 12:979-816
Bahat-Stroomza M, Gilgun-Sherki Y, Offen D, Panet H, Saada A, Krool-Galron N, Barzilai A, Atlas D, Melamed E. 2005. A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease. Eur J Neurosci. 21:637-46
Elpeleg O, Miller C, Hershkovitz E, Bitner-Glindzicz M, Bondi-Rubinstein G, Rahman S, Pagnamenta A, Eshhar S, Saada A. 2005 Deficiency of the ADP-Forming Succinyl-CoA Synthase Activity Is Associated with Encephalomyopathy and Mitochondrial DNA Depletion. Am J Hum Genet 76:1081-1086.
Leshinsky-Silver E, Lev D, Tzofi-Berman Z, Cohen S, Saada A, Yanoov-Sharav M, Gilad E, Lerman-Sagie T. 2005 Fulminant neurological deterioration in a neonate with Leigh syndrome due to a maternally transmitted missense mutation in the mitochondrial ND3 gene.. Biochem Biophys Res Commun 334 582-587.